Sagiment Biosciences Inc (SGMT)
NASDAQ
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Assets | 27.25M | 21.5M | 102.93M | 96.72M | 194.53M |
Total Current Assets | 27.05M | 21.35M | 102.82M | 96.65M | 194.49M |
Cash and Equivalents | 12.34M | 18.51M | 101.84M | 75.14M | 176.78M |
Total Non-Current Assets | 205k | 144k | 109k | 73k | 37k |
Total Liabilities | 5.33M | 5.29M | 5.05M | 5.65M | 4.51M |
Total Current Liabilities | 5.29M | 5.29M | 5.05M | 5.65M | 4.51M |
Total Non-Current Liabilities | 45k | 5k | 1,000 | 0 | 0 |
Common Equity | 1,000 | 1,000 | 2k | 2k | 3k |
Retained Earnings | -228.46M | -235.24M | -241.59M | -249.74M | -256.37M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 59.03M | 33.03M | 96.72M |
Total Current Assets | 58.66M | 32.79M | 96.65M |
Cash and Equivalents | 56.73M | 158k | 75.14M |
Total Non-Current Assets | -158.26M | -186.95M | 91.07M |
Total Liabilities | 2.67M | 5.36M | 5.65M |
Total Current Liabilities | 2.44M | 5.28M | 5.65M |
Total Non-Current Liabilities | 231k | 82k | 0 |
Total Equity | -158.26M | -186.95M | 91.07M |
Common Equity | 1,000 | 1,000 | 2k |
Retained Earnings | -191.37M | -221.87M | -249.74M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.